These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21780551)

  • 41. Probiotics: preventing antibiotic-associated diarrhea.
    Jones K
    J Spec Pediatr Nurs; 2010 Apr; 15(2):160-2. PubMed ID: 20367786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probiotics: facts and myths.
    Senok AC; Ismaeel AY; Botta GA
    Clin Microbiol Infect; 2005 Dec; 11(12):958-66. PubMed ID: 16307549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical gastroenterology--luxury or standard of service in gastroenterology?].
    Birkner B
    Z Gastroenterol; 2005 Dec; 43(12):1285-92. PubMed ID: 16315123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.
    Hudson LE; Fasken MB; McDermott CD; McBride SM; Kuiper EG; Guiliano DB; Corbett AH; Lamb TJ
    PLoS One; 2014; 9(11):e112660. PubMed ID: 25391025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The place of probiotics in human intestinal infections.
    Sullivan A; Nord CE
    Int J Antimicrob Agents; 2002 Nov; 20(5):313-9. PubMed ID: 12431865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Yeast Probiotics in Gastrointestinal Conditions: An Overview.
    Puri AS
    J Assoc Physicians India; 2023 Apr; 71(4):11-12. PubMed ID: 37355796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A commentary on the safety of probiotics.
    Shanahan F
    Gastroenterol Clin North Am; 2012 Dec; 41(4):869-76. PubMed ID: 23101692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do probiotics have a therapeutic role in gastroenterology?
    Limdi JK; O'Neill C; McLaughlin J
    World J Gastroenterol; 2006 Sep; 12(34):5447-57. PubMed ID: 17006980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of microencapsulation on
    Ghorbani-Choboghlo H; Nikaein D; Khosravi AR; Rahmani R; Farahnejad Z
    Iran J Microbiol; 2019 Apr; 11(2):160-165. PubMed ID: 31341571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders.
    Su GL; Ko CW; Bercik P; Falck-Ytter Y; Sultan S; Weizman AV; Morgan RL
    Gastroenterology; 2020 Aug; 159(2):697-705. PubMed ID: 32531291
    [No Abstract]   [Full Text] [Related]  

  • 51. Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.
    Sulik-Tyszka B; Snarski E; Niedźwiedzka M; Augustyniak M; Myhre TN; Kacprzyk A; Swoboda-Kopeć E; Roszkowska M; Dwilewicz-Trojaczek J; Jędrzejczak WW; Wróblewska M
    Probiotics Antimicrob Proteins; 2018 Jun; 10(2):350-355. PubMed ID: 28948565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What are the indications for using probiotics in children?
    Szajewska H
    Arch Dis Child; 2016 Apr; 101(4):398-403. PubMed ID: 26347386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of pH conditions on the viability of Saccharomyces boulardii yeast.
    Graff S; Chaumeil JC; Boy P; Lai-Kuen R; Charrueau C
    J Gen Appl Microbiol; 2008 Aug; 54(4):221-7. PubMed ID: 18802321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group.
    Schoenfeld P; Cook D; Hamilton F; Laine L; Morgan D; Peterson W
    Gastroenterology; 1998 Jun; 114(6):1318-25. PubMed ID: 9609770
    [No Abstract]   [Full Text] [Related]  

  • 55. Consideration for Use of Probiotics in Gastrointestinal Diseases: Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2020 Aug; 159(2):706. PubMed ID: 32544395
    [No Abstract]   [Full Text] [Related]  

  • 56. AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.
    Preidis GA; Weizman AV; Kashyap PC; Morgan RL
    Gastroenterology; 2020 Aug; 159(2):708-738.e4. PubMed ID: 32531292
    [No Abstract]   [Full Text] [Related]  

  • 57. Saccharomyces boulardii effects on gastrointestinal diseases.
    Zanello G; Meurens F; Berri M; Salmon H
    Curr Issues Mol Biol; 2009; 11(1):47-58. PubMed ID: 18780946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic Engineering of Probiotic Saccharomyces boulardii.
    Liu JJ; Kong II; Zhang GC; Jayakody LN; Kim H; Xia PF; Kwak S; Sung BH; Sohn JH; Walukiewicz HE; Rao CV; Jin YS
    Appl Environ Microbiol; 2016 Apr; 82(8):2280-2287. PubMed ID: 26850302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spotlight: Probiotics Guidelines.
    Su GL; Ko CW; Bercik P; Morgan RL; Weizman AV; Kashyap P; Preidis GA
    Gastroenterology; 2020 Aug; 159(2):707. PubMed ID: 32738195
    [No Abstract]   [Full Text] [Related]  

  • 60. Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii.
    Periti P; Tonelli F
    J Chemother; 2001 Oct; 13(5):473-93. PubMed ID: 11760212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.